Celularity (CELU) Stock: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$1.56
0.10 (6.85%)
â˛
5d:
-2.5%
30d:
+8.71%
90d:
+106.6%
WAIT
LOW Confidence
Analysis Updated: Oct 8, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CELU is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CELU is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $1.56, which is considered fair relative to its 30-day fair value range of $1.26 to $1.67.
Technical Outlook: Technically, CELU is in a uptrend. Immediate support is located at $1.28, while resistance sits at $1.80. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: CELU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+71.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CELU is in a uptrend. Immediate support is located at $1.28, while resistance sits at $1.80. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: CELU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+71.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.26 -
$1.67
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 71.2% below Wall St target ($2.50)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.26 -
$1.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.80
Current Trend
Uptrend
Technical data as of
Oct 9, 2026
Fundamental Context
Wall Street Target
$2.50
(+71.2%)
Revenue Growth (YoY)
-66.3%
Earnings Growth (YoY)
-61.3%
Share & Embed Analysis
Last updated: October 09, 2026 5:00 PM ET
Data refreshes hourly during market hours. Next update: 6:00 PM
Data refreshes hourly during market hours. Next update: 6:00 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$198 | 51 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$110 | 67 BUY |
|
CGON
CG Oncology, Inc. CommonâĻ |
STRONG BUY
15 analysts |
$91 | 70 BUY |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$682 | 43 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 57 HOLD |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
